BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28663030)

  • 1. Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats.
    Movassaghi M; Shabihkhani M; Hojat SA; Williams RR; Chung LK; Im K; Lucey GM; Wei B; Mareninov S; Wang MW; Ng DW; Tashjian RS; Magaki S; Perez-Rosendahl M; Yang I; Khanlou N; Vinters HV; Liau LM; Nghiemphu PL; Lai A; Cloughesy TF; Yong WH
    Exp Mol Pathol; 2017 Aug; 103(1):87-93. PubMed ID: 28663030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Evaluation of IDH Mutation Status in Formalin-Fixed Paraffin-Embedded Tissue in Gliomas.
    Nelson EJ; Gubbiotti MA; Carlin AM; Nasrallah MP; Van Deerlin VM; Herlihy SE
    Mol Diagn Ther; 2023 May; 27(3):371-381. PubMed ID: 36690887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas.
    Diplas BH; Liu H; Yang R; Hansen LJ; Zachem AL; Zhao F; Bigner DD; McLendon RE; Jiao Y; He Y; Waitkus MS; Yan H
    Neuro Oncol; 2019 Mar; 21(4):440-450. PubMed ID: 30346624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.
    Nikiforova MN; Wald AI; Melan MA; Roy S; Zhong S; Hamilton RL; Lieberman FS; Drappatz J; Amankulor NM; Pollack IF; Nikiforov YE; Horbinski C
    Neuro Oncol; 2016 Mar; 18(3):379-87. PubMed ID: 26681766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.
    Fumagalli C; Ranghiero A; Gandini S; Corso F; Taormina S; De Camilli E; Rappa A; Vacirca D; Viale G; Guerini-Rocco E; Barberis M
    Breast Cancer Res; 2020 Oct; 22(1):107. PubMed ID: 33059724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the rapid Idylla IDH1-2 mutation assay in FFPE glioma samples.
    Solomon JP; Munoz-Zuluaga C; Slocum C; Dillard A; Cong L; Wang J; Lindeman N; Kluk M; Liechty B; Pisapia D; Rennert H; Velu PD
    Diagn Pathol; 2024 May; 19(1):70. PubMed ID: 38796421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiles of gliomas in formalin-fixed paraffin-embedded material.
    Gravendeel LA; de Rooi JJ; Eilers PH; van den Bent MJ; Sillevis Smitt PA; French PJ
    Br J Cancer; 2012 Jan; 106(3):538-45. PubMed ID: 22187034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult brainstem gliomas: Correlation of clinical and molecular features.
    Theeler BJ; Ellezam B; Melguizo-Gavilanes I; de Groot JF; Mahajan A; Aldape KD; Bruner JM; Puduvalli VK
    J Neurol Sci; 2015; 353(1-2):92-7. PubMed ID: 25934342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Metabolomic Markers in Frozen or Formalin-Fixed and Paraffin-Embedded Samples of Diffuse Glioma from Adults.
    Chardin D; Jing L; Chazal-Ngo-Mai M; Guigonis JM; Rigau V; Goze C; Duffau H; Virolle T; Pourcher T; Burel-Vandenbos F
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative molecular profiling of routine clinical prostate cancer specimens.
    Grasso CS; Cani AK; Hovelson DH; Quist MJ; Douville NJ; Yadati V; Amin AM; Nelson PS; Betz BL; Liu CJ; Knudsen KE; Cooney KA; Feng FY; McDaniel AS; Tomlins SA
    Ann Oncol; 2015 Jun; 26(6):1110-1118. PubMed ID: 25735316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATRX in Diffuse Gliomas With its Mosaic/Heterogeneous Expression in a Subset.
    Purkait S; Miller CA; Kumar A; Sharma V; Pathak P; Jha P; Sharma MC; Suri V; Suri A; Sharma BS; Fulton RS; Kale SS; Dahiya S; Sarkar C
    Brain Pathol; 2017 Mar; 27(2):138-145. PubMed ID: 26833422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer.
    Kim S; Lee J; Hong ME; Do IG; Kang SY; Ha SY; Kim ST; Park SH; Kang WK; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kim DH; Kim KM
    PLoS One; 2014; 9(11):e111693. PubMed ID: 25372287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TERT Immunohistochemistry as a Surrogate Marker for TERT Promoter Mutations in Infiltrating Gliomas.
    Dono A; Moosvi AM; Goli PS; Bellman AC; Aung PP; Esquenazi Y; Ballester LY
    Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):288-294. PubMed ID: 36952585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Profiling and Targeted Therapies in Gliomas.
    Felistia Y; Wen PY
    Curr Neurol Neurosci Rep; 2023 Oct; 23(10):627-636. PubMed ID: 37812369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues.
    Vaca-Paniagua F; Alvarez-Gomez RM; Maldonado-Martínez HA; Pérez-Plasencia C; Fragoso-Ontiveros V; Lasa-Gonsebatt F; Herrera LA; Cantú D; Bargallo-Rocha E; Mohar A; Durand G; Forey N; Voegele C; Vallée M; Le Calvez-Kelm F; McKay J; Ardin M; Villar S; Zavadil J; Olivier M
    PLoS One; 2015; 10(5):e0126762. PubMed ID: 25961742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated genomic analysis of human glioblastoma multiforme.
    Parsons DW; Jones S; Zhang X; Lin JC; Leary RJ; Angenendt P; Mankoo P; Carter H; Siu IM; Gallia GL; Olivi A; McLendon R; Rasheed BA; Keir S; Nikolskaya T; Nikolsky Y; Busam DA; Tekleab H; Diaz LA; Hartigan J; Smith DR; Strausberg RL; Marie SK; Shinjo SM; Yan H; Riggins GJ; Bigner DD; Karchin R; Papadopoulos N; Parmigiani G; Vogelstein B; Velculescu VE; Kinzler KW
    Science; 2008 Sep; 321(5897):1807-12. PubMed ID: 18772396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-institutional study to evaluate the feasibility of next-generation sequencing and genomic analysis using formalin-fixed, paraffin-embedded biopsies of gastric cancer.
    Kanda M; Terashima M; Kinoshita T; Yabusaki H; Tokunaga M; Kodera Y
    Gastric Cancer; 2023 Jan; 26(1):108-115. PubMed ID: 36369312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing.
    Euskirchen P; Bielle F; Labreche K; Kloosterman WP; Rosenberg S; Daniau M; Schmitt C; Masliah-Planchon J; Bourdeaut F; Dehais C; Marie Y; Delattre JY; Idbaih A
    Acta Neuropathol; 2017 Nov; 134(5):691-703. PubMed ID: 28638988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Biomarker Assays for
    Lassman AB; Roberts-Rapp L; Sokolova I; Song M; Pestova E; Kular R; Mullen C; Zha Z; Lu X; Gomez E; Bhathena A; Maag D; Kumthekar P; Gan HK; Scott AM; Guseva M; Holen KD; Ansell PJ; van den Bent MJ
    Clin Cancer Res; 2019 Jun; 25(11):3259-3265. PubMed ID: 30796037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative Tissue Fixation Protocols Dramatically Reduce the Impact of DNA Artifacts, Unraveling the Interpretation of Clinical Comprehensive Genomic Profiling.
    Berrino E; Bellomo SE; Chesta A; Detillo P; Bragoni A; Gagliardi A; Naccarati A; Cereda M; Witel G; Sapino A; Bussolati B; Bussolati G; Marchiò C
    Lab Invest; 2024 Jan; 104(1):100280. PubMed ID: 38345263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.